FIELD: medicine. SUBSTANCE: desired product has common formula 1 CHCH-CHCH-N-CCR2-CR1N where R1 is phenyl, R2 is group having 2-7 formula, R3 is alkyl, hydroxyalkyl, alkoxyalkyl, alkoxycarbonyl, carbomoylalkyl or N, N-dialkyl ( or they forms together puridine ring); R4 is carboxyalkyl or alkoxycarbonylalkyl; R5 - H, carboxy - or cyano-group, alkoxycarbonyl; R6 is alkoxycarbonylalkyl; R7 - alkyl, carboxyalkyl, alkoxycarbonylalkyl; R8 is alkyl, carboxyalkyl or alkoxycarbonyl; R9 is carboxyalkyl or alkoxy-carbonylalkyl; R10 is H or OH; in all these cases lower alkyls being used. Reagent 1 is product having formula 1 where instead of R2 are used groups having 2-7 formulae without any groups at corresponding nitrogen atoms from R3-R10, or salt of this product. Reagent 2 is compound having formula QY where Q is R3-R9, Y is removing group. Desired product is prepared by interaction of these two reagents. If if is necessary lower alkyl group is removed of thus prepared product in which R3-R9 and each of them are (lower ) alkoxycarbonyl(lower)alkyl. Structural formulae 2-7 are given. EFFECT: improves efficiency of the method.
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF PYRAZOLO-[1,5-A]-PYRIDINE OR THEIR PHARMACEUTICAL ACCEPTABLE SALTS AND METHOD OF THEIR SYNTHESIS | 1992 |
|
RU2069662C1 |
DERIVATIVES OF INDOLYLPYPERIDINE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1991 |
|
RU2039056C1 |
METHOD OF SYNTHESIS OF PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1990 |
|
RU2021990C1 |
TRICYCLE COMPOUNDS OR THEIRS PHARMACEUTICALLY ACCEPTABLE SALTS | 1989 |
|
RU2007406C1 |
PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1992 |
|
RU2043365C1 |
METHOD OF SYNTHESIS OF THIAZOLE DERIVATIVES OR THEIRS SALTS WITH HALOID ACID | 1990 |
|
RU2010026C1 |
METHOD OF SYNTHESIS OF CEPHEM COMPOUNDS OR THEIR ACID-ADDITIVE SALTS | 1988 |
|
RU2017744C1 |
METHOD OF SYNTHESIS OF ALKANESULFONANILIDE DERIVATIVES OR THEIRS PHARMACEUTICALLY ACCEPTABLE SALTS | 1988 |
|
RU2012557C1 |
PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF DISEASE TREATMENT INTERMEDIARY AGENT OF THAT IS TACHIKININ | 1991 |
|
RU2073683C1 |
THIAZOLE DERIVATIVES | 1991 |
|
RU2048468C1 |
Authors
Dates
1994-02-15—Published
1990-01-22—Filed